等待開盤 08-06 09:30:00 美东时间
0.000
0.00%
An independent Data Safety Monitoring Board has recommended continuing enrollment in Benitec Biopharma's Phase 1b/2a clinical study for BB-301 after reviewing safety data from Cohort 1, with Cohort 2 enrollment expected to begin in Q4 2025.
07-09 12:00
标普生物科技精选行业指数本周强势领跑!油价暴跌并抹去俄乌冲突以来所有涨幅,做空原油ETF周涨近17%;强劲非农对美联储意味着什么?小摩:9月加息75个基点>>
2022-08-07 18:54